emtricitabine has been researched along with Skin Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kerkemeyer, KLS; Lai, FYX; Mar, A | 1 |
Chima-Okereke, C; Sivaprakasam, V | 1 |
2 other study(ies) available for emtricitabine and Skin Neoplasms
Article | Year |
---|---|
Kaposi's Sarcoma Occurring in HIV Infection Controlled on HAART.
Topics: Ankle; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Emtricitabine; Foot; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lymphedema; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Sarcoma, Kaposi; Skin Neoplasms; Sustained Virologic Response; Tenofovir; Viral Load | 2020 |
An interesting case of 'diabetic foot ulcer' in an HIV-positive patient.
Topics: Adenine; Aged; Antiretroviral Therapy, Highly Active; Biopsy; Deoxycytidine; Diabetes Mellitus, Type 2; Diabetic Foot; Emtricitabine; Herpesvirus 8, Human; HIV Infections; HIV Seropositivity; Humans; Male; Organophosphonates; Sarcoma, Kaposi; Skin Neoplasms; Tenofovir; Treatment Outcome; Ulcer | 2015 |